• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs 在心脏发育和疾病中的作用。

miRNAs in Heart Development and Disease.

机构信息

Cardiovascular Development Group, Department of Experimental Biology, University of Jaen, 23071 Jaen, Spain.

Stem Cells and Development Laboratory, iNOVA4Health, NOVA Medical School|Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, 1150-082 Lisbon, Portugal.

出版信息

Int J Mol Sci. 2024 Jan 30;25(3):1673. doi: 10.3390/ijms25031673.

DOI:10.3390/ijms25031673
PMID:38338950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10855082/
Abstract

Cardiovascular diseases (CVD) are a group of disorders that affect the heart and blood vessels. They include conditions such as myocardial infarction, coronary artery disease, heart failure, arrhythmia, and congenital heart defects. CVDs are the leading cause of death worldwide. Therefore, new medical interventions that aim to prevent, treat, or manage CVDs are of prime importance. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the posttranscriptional level and play important roles in various biological processes, including cardiac development, function, and disease. Moreover, miRNAs can also act as biomarkers and therapeutic targets. In order to identify and characterize miRNAs and their target genes, scientists take advantage of computational tools such as bioinformatic algorithms, which can also assist in analyzing miRNA expression profiles, functions, and interactions in different cardiac conditions. Indeed, the combination of miRNA research and bioinformatic algorithms has opened new avenues for understanding and treating CVDs. In this review, we summarize the current knowledge on the roles of miRNAs in cardiac development and CVDs, discuss the challenges and opportunities, and provide some examples of recent bioinformatics for miRNA research in cardiovascular biology and medicine.

摘要

心血管疾病(CVD)是一组影响心脏和血管的疾病。它们包括心肌梗死、冠状动脉疾病、心力衰竭、心律失常和先天性心脏缺陷等病症。CVD 是全球死亡的主要原因。因此,旨在预防、治疗或管理 CVD 的新医疗干预措施至关重要。微小 RNA(miRNA)是一种小的非编码 RNA,可在转录后水平调节基因表达,在心脏发育、功能和疾病等各种生物学过程中发挥重要作用。此外,miRNA 还可以作为生物标志物和治疗靶点。为了识别和描述 miRNA 及其靶基因,科学家们利用计算工具,如生物信息算法,这些工具还可以帮助分析不同心脏状况下 miRNA 的表达谱、功能和相互作用。事实上,miRNA 研究和生物信息算法的结合为理解和治疗 CVD 开辟了新途径。在这篇综述中,我们总结了 miRNA 在心脏发育和 CVD 中的作用的现有知识,讨论了挑战和机遇,并提供了一些心血管生物学和医学中 miRNA 研究的最新生物信息学的例子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78af/10855082/e84782d7bde2/ijms-25-01673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78af/10855082/e84782d7bde2/ijms-25-01673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78af/10855082/e84782d7bde2/ijms-25-01673-g001.jpg

相似文献

1
miRNAs in Heart Development and Disease.miRNAs 在心脏发育和疾病中的作用。
Int J Mol Sci. 2024 Jan 30;25(3):1673. doi: 10.3390/ijms25031673.
2
MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.微小RNA作为心血管疾病的候选药物靶点
Curr Drug Targets. 2017;18(4):463-472. doi: 10.2174/1389450117666160301101221.
3
MicroRNA-30 and 145 as Targets for the Treatment of Cardiovascular Diseases: Therapeutic Feasibility and Challenges.miRNA-30 和 145 作为心血管疾病治疗靶点:治疗的可行性和挑战。
Curr Pharm Des. 2021;27(37):3858-3870. doi: 10.2174/1381612826666201211120822.
4
MicroRNAs: roles in cardiovascular development and disease.微小 RNA:在心血管发育和疾病中的作用。
Cardiovasc Pathol. 2021 Jan-Feb;50:107296. doi: 10.1016/j.carpath.2020.107296. Epub 2020 Oct 3.
5
New Insight into Mechanisms of Cardiovascular Diseases: An Integrative Analysis Approach to Identify TheranoMiRNAs.心血管疾病机制的新见解:一种综合分析方法来识别治疗性 miRNA。
Int J Mol Sci. 2023 Apr 5;24(7):6781. doi: 10.3390/ijms24076781.
6
miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives.miRNA 在心脑血管疾病中的失调:现状与展望。
Int J Mol Sci. 2023 Mar 8;24(6):5192. doi: 10.3390/ijms24065192.
7
MicroRNAs in cardiovascular diseases.心血管疾病中的微小RNA
Med Rev (2021). 2022 Apr 26;2(2):140-168. doi: 10.1515/mr-2021-0001. eCollection 2022 Apr.
8
microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia.微小RNA:急性心肌缺血的潜在生物标志物和治疗靶点
Curr Vasc Pharmacol. 2015;13(3):305-15. doi: 10.2174/15701611113119990011.
9
The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis.miRNAs 在调节血小板活性及相关疾病中的作用——生物信息学分析。
Platelets. 2022 Oct 3;33(7):1052-1064. doi: 10.1080/09537104.2022.2042233. Epub 2022 Mar 14.
10
[MicroRNA--a new diagnostic tool in coronary artery disease and myocardial infarction].[微小RNA——冠状动脉疾病和心肌梗死的一种新型诊断工具]
Postepy Hig Med Dosw (Online). 2014 Apr 28;68:410-8. doi: 10.5604/17322693.1100348.

引用本文的文献

1
Foxf1-mediated co-regulation of miR-495 and let-7c modulates epicardial cell migration and myocardial specification.Foxf1介导的miR-495和let-7c的共同调节作用调控心外膜细胞迁移和心肌特化。
Cell Mol Life Sci. 2025 Jun 25;82(1):254. doi: 10.1007/s00018-025-05735-4.
2
Cell Reprogramming, Transdifferentiation, and Dedifferentiation Approaches for Heart Repair.用于心脏修复的细胞重编程、转分化和去分化方法。
Int J Mol Sci. 2025 Mar 27;26(7):3063. doi: 10.3390/ijms26073063.
3
X-Chromosome-Linked miRNAs Regulate Sex Differences in Cardiac Physiology.

本文引用的文献

1
Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction.心肌RNA测序揭示射血分数保留的心力衰竭新的潜在治疗靶点。
Biomedicines. 2023 Jul 28;11(8):2131. doi: 10.3390/biomedicines11082131.
2
miRNA-103-3p-Hlf regulates apoptosis and autophagy by targeting hepatic leukaemia factor in heart failure.miRNA-103-3p-Hlf 通过靶向肝母细胞瘤转录因子调控心力衰竭中心脏细胞的凋亡和自噬。
ESC Heart Fail. 2023 Oct;10(5):3038-3045. doi: 10.1002/ehf2.14493. Epub 2023 Aug 10.
3
Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice.
X染色体连锁的微小RNA调节心脏生理学中的性别差异。
Circ Res. 2025 Jan 31;136(3):258-275. doi: 10.1161/CIRCRESAHA.124.325447. Epub 2024 Dec 30.
4
Exosomes and miRNAs in Cardiovascular Diseases and Transcatheter Pulmonary Valve Replacement: Advancements, Gaps and Perspectives.心血管疾病与经导管肺动脉瓣置换中的外泌体和微小RNA:进展、差距与展望
Int J Mol Sci. 2024 Dec 21;25(24):13686. doi: 10.3390/ijms252413686.
5
The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk.肌微RNA-133a-3p、-133b和-206失调在心血管疾病风险中的潜在作用
Int J Mol Sci. 2024 Nov 27;25(23):12772. doi: 10.3390/ijms252312772.
6
Binding-driven forward tearing protospacer activated CRISPR-Cas12a system and applications for microRNA detection.基于结合的正向撕裂原间隔激活的 CRISPR-Cas12a 系统及其在 microRNA 检测中的应用。
J Nanobiotechnology. 2024 Nov 8;22(1):684. doi: 10.1186/s12951-024-02915-5.
7
Global research landscape on the genetics of congenital heart disease: A bibliometric and visualized analysis via VOSviewer and CiteSpace.全球先天性心脏病遗传学研究格局:基于 VOSviewer 和 CiteSpace 的文献计量和可视化分析。
Medicine (Baltimore). 2024 Oct 25;103(43):e40261. doi: 10.1097/MD.0000000000040261.
8
Role of NHERF1 in MicroRNA Landscape Changes in Aging Mouse Kidneys.NHERF1 在衰老小鼠肾脏中 microRNA 景观变化中的作用。
Biomolecules. 2024 Aug 23;14(9):1048. doi: 10.3390/biom14091048.
9
Candidate Signature miRNAs from Secreted miRNAome of Human Lung Microvascular Endothelial Cells in Response to Different Oxygen Conditions: A Pilot Study.候选签名 miRNA 来自不同氧条件下人肺微血管内皮细胞分泌 miRNAome:一项初步研究。
Int J Mol Sci. 2024 Aug 13;25(16):8798. doi: 10.3390/ijms25168798.
10
Exosomal miRNA Changes Associated with Restoration to Sinus Rhythm in Atrial Fibrillation Patients.与心房颤动患者窦性节律恢复相关的外泌体 miRNA 变化。
Int J Mol Sci. 2024 Mar 29;25(7):3861. doi: 10.3390/ijms25073861.
微小 RNA 在致心律失常性心肌病中的作用:作为生物标志物转化为临床实践。
Transl Res. 2023 Sep;259:72-82. doi: 10.1016/j.trsl.2023.04.003. Epub 2023 Apr 25.
4
microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation.微小RNA作为心房颤动患者主要不良心血管事件风险的生物标志物
Front Cardiovasc Med. 2023 Feb 21;10:1135127. doi: 10.3389/fcvm.2023.1135127. eCollection 2023.
5
Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making.整合冠状动脉粥样硬化负担及进展与冠状动脉疾病危险因素以指导治疗决策
Am J Med. 2023 Mar;136(3):260-269.e7. doi: 10.1016/j.amjmed.2022.10.021. Epub 2022 Dec 10.
6
Systems Biology in Chronic Heart Failure-Identification of Potential miRNA Regulators.慢性心力衰竭中的系统生物学——潜在miRNA调节因子的鉴定
Int J Mol Sci. 2022 Dec 3;23(23):15226. doi: 10.3390/ijms232315226.
7
miR-1 Mediated AMPK Pathway on Cardiomyocyte Apoptosis in Hypertensive Rats.miR-1介导的AMPK信号通路对高血压大鼠心肌细胞凋亡的影响
Cell Mol Biol (Noisy-le-grand). 2022 Jul 31;68(7):135-140. doi: 10.14715/cmb/2022.68.7.22.
8
The Role of Inflammation in Cardiovascular Disease.炎症在心血管疾病中的作用。
Int J Mol Sci. 2022 Oct 26;23(21):12906. doi: 10.3390/ijms232112906.
9
A Survey on Computational Methods for Investigation on ncRNA-Disease Association through the Mode of Action Perspective.ncRNA 疾病关联的计算方法研究综述——从作用模式角度
Int J Mol Sci. 2022 Sep 29;23(19):11498. doi: 10.3390/ijms231911498.
10
miRModuleNet: Detecting miRNA-mRNA Regulatory Modules.miRModuleNet:检测微小RNA-信使核糖核酸调控模块
Front Genet. 2022 Apr 12;13:767455. doi: 10.3389/fgene.2022.767455. eCollection 2022.